Aortic Valve Disease, a cardiac condition with significant implications, arises when the aortic valve, a crucial component in regulating blood flow from the heart, malfunctions. This malfunction manifests as either aortic stenosis, characterized by narrowing of the valve, or aortic regurgitation, where the valve fails to close properly, resulting in inefficient blood circulation. A myriad of factors, such as congenital abnormalities and heart-related conditions, contribute to the development of this disease. Recognizable symptoms encompass chest pain, fatigue, shortness of breath, and even fainting. Successful management of Aortic Valve Disease hinges on prompt diagnosis and intervention. Treatment options span from medication to surgical procedures, such as valve repair or replacement. A comprehensive approach, integrating medical expertise, diagnostic advancements, and cutting-edge therapies, is imperative for effectively addressing Aortic Valve Disease and enhancing the overall cardiovascular well-being of those affected.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt